494
Participants
Start Date
May 31, 2011
Primary Completion Date
August 31, 2011
Ambroxol Spray
low dose Ambroxol Spray
Ambroxol Spray
medium dose Ambroxol Spray
Ambroxol Spray
high dose Ambroxol Spray
Placebo Spray
Placebo Spray
18.504.27015 Boehringer Ingelheim Investigational Site, Bloemfontein
18.504.27005 Boehringer Ingelheim Investigational Site, Cape Town
18.504.27011 Boehringer Ingelheim Investigational Site, Cape Town
18.504.27013 Boehringer Ingelheim Investigational Site, Cape Town
18.504.27014 Boehringer Ingelheim Investigational Site, Cape Town
18.504.27008 Boehringer Ingelheim Investigational Site, Durban
18.504.27010 Boehringer Ingelheim Investigational Site, Durban
18.504.27001 Boehringer Ingelheim Investigational Site, Johannesburg
18.504.27004 Boehringer Ingelheim Investigational Site, Klipspruit West
18.504.27003 Boehringer Ingelheim Investigational Site, Krugersdorp
18.504.27002 Boehringer Ingelheim Investigational Site, Lenasia
18.504.27006 Boehringer Ingelheim Investigational Site, Newtown
18.504.27012 Boehringer Ingelheim Investigational Site, Paarl
18.504.27007 Boehringer Ingelheim Investigational Site, Pretoria
18.504.27009 Boehringer Ingelheim Investigational Site, Sydenham
Lead Sponsor
Boehringer Ingelheim
INDUSTRY